# Kimyrsa

NDC: 70842-225
Generic name: oritavancin diphosphate
Labeler / Manufacturer: Melinta Therapeutics, LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20210323

FDA application: NDA214155

## Active ingredients

- ORITAVANCIN DIPHOSPHATE: 1200 mg/40mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"70842-225"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=70842-225
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=5e755c40-6e73-4572-b474-4d8a131693d1